Back to Search
DENISE PINON, MD, MPH
MD, MPH
Family Medicine Physician
NPI: 1679879639IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Class of 2014
Research & Publications (20)
Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.
PMID 19441839·Biochemistry·2009
7-preclinical
Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor.
PMID 18700727·Biochemistry·2008
7-preclinical
Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
PMID 18467541·Mol Pharmacol·2008
4-observational
Exploration of the endogenous agonist mechanism for activation of secretin and VPAC1 receptors using synthetic glycosylated peptides.
PMID 18409024·J Mol Neurosci·2008
7-preclinical
Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors.
PMID 18372345·Mol Endocrinol·2008
7-preclinical
Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor.
PMID 17726027·J Biol Chem·2007
7-preclinical
Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
PMID 17475809·Mol Pharmacol·2007
7-preclinical
Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.
PMID 17144663·Biochemistry·2006
7-preclinical
Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors.
PMID 16857665·J Biol Chem·2006
7-preclinical
Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor.
PMID 16779661·Biosci Rep·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 975 SERENO DR
VALLEJO, CA 94589 - Phone
- (707) 651-1000
Quick Facts
- NPI
- 1679879639
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile